What Pharma Solutions at IFF does

Pharma Solutions at IFF is a global provider of polymer-based pharmaceutical excipients, dietary supplement ingredients, and biomedical biopolymers, now operating as part of Roquette Frères S.A.'s Health & Pharma Solutions division following Roquette's May 2025 acquisition of the business from International Flavors & Fragrances (IFF). The company's core technology platform centers on specialized polymers including cellulosics (METHOCEL HPMC), polyethylene oxide polymers (POLYOX), high-quality biopolymers (METHONOVA, NovaMatrix), and starch-derived alginate technologies, serving pharmaceutical manufacturers across the entire drug development pipeline, dietary supplement companies seeking clean-label formats, and biomedical and life science firms requiring specialized biopolymer solutions.

The business operates a B2B enterprise sales model through direct sales teams supported by global customer support, targeting large pharmaceutical manufacturers, nutraceutical producers, and biotechnology companies worldwide. Revenue is generated through transaction-based sale of specialized excipients and ingredients, with quote-based pricing for pharmaceutical-grade materials. Key product lines include POLYOX polyethylene oxide polymers for controlled release applications, METHOCEL HPMC including a low nitrite variant addressing nitrosamine mitigation concerns, METHONOVA biomedical solutions, and NovaMatrix biopolymers for life science applications. The company's competitive position is anchored in proprietary technology, global manufacturing scale, regulatory compliance expertise, and scientific know-how demonstrated through thought leadership platforms including POLYOX Academy and Controlled Release resources.

Recent strategic activity includes the establishment of a new Pharmaceutical Innovation Center in Latin America (October 2025), the launch of DS 700 water-resistant capsule technology and three new alginate-based formulations (April 2026), and recognition with the 2025 NIE New Ingredient Award for Low Nitrite METHOCEL HPMC. The business serves a global customer base across pharmaceutical manufacturing, dietary supplements, and biomedical and biologicals segments, with particular strength in excipient innovation for controlled release and drug delivery applications.

Name

Pharma Solutions at IFF

Legal name

IFF Pharma Solutions

Website

https://pharma.iff.com

Company type

Private

Operating status

Acquired

Headcount range

5,001–10,000 employees

Short description

Pharma Solutions at IFF, now part of Roquette Frères S.A., is a global provider of polymer-based pharmaceutical excipients, dietary supplement ingredients, and biomedical biopolymers, serving pharmaceutical manufacturers, nutraceutical companies, and life science firms worldwide through proprietary brands including POLYOX, METHOCEL, METHONOVA, and NovaMatrix.

Ownership category

akta.pro rank

Product category

Pharmaceutical Excipients

NAICS

Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (3254), Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing (3252)

SIC

Medicinal Chemicals & Botanical Products (2833), Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) (2820), Industrial Organic Chemicals (2860)

akta.pro primary industry

Medical & Food-Contact Specialty Compounds (IMANABAK)

akta.pro secondary industries

Biodegradable Polymers & Resins (PLA, PHA, PBS, PBAT) (IMAEAOAA), Bio-Based & Biodegradable Compounds (PLA/PHA/Starch Blends) (IMANABAF)

Keywords

• Pharmaceutical excipients
• Drug delivery systems
• Cellulose derivatives
• Controlled release polymers
• Biopolymer solutions

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Excipients and Ingredients: Sale of specialized pharmaceutical excipients including cellulosics, biopolymers, and synthetic polymers to pharmaceutical manufacturers for drug formulation and manufacturing
2. Biomedical and Biotechnology Solutions: Supply of biopolymers and specialized materials for biomedical research, drug delivery systems, and life science applications
3. Dietary Supplement Ingredients: Provision of clean-label ingredients and formulations for dietary supplements, nutraceuticals, and wellness products

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Pharma Solutions at IFF manufactures and supplies pharmaceutical excipients and specialty polymer ingredients — including cellulosics, seaweed extracts, ultrapure biopolymers, and specialized synthetic polymers — for use in drug formulation, controlled release drug delivery, dietary supplement manufacturing, and biomedical/life science applications. Its proprietary product portfolio encompasses POLYOX™ polyethylene oxide polymers, METHOCEL™ HPMC, METHONOVA™ biopolymers, NovaMatrix® and NovaMatrix-3D™ platforms, starch-derived alginate technologies, and the DS 700 water-resistant capsule.

Product overview

Roquette Health & Pharma Solutions (formerly IFF Pharma Solutions, acquired May 2025) operates as a multi-segment platform providing sustainable polymer-based solutions across three core areas: Pharmaceuticals (cellulosics, seaweed extracts, biopolymers, synthetic polymers), Dietary Supplements (clean-label formats like gummies and softgels), and Biomedical & Biologicals (biopolymers via METHONOVA™, NovaMatrix®, NovaMatrix-3D™). The portfolio includes key product lines such as POLYOX™ polyethylene oxide polymers and METHOCEL HPMC for controlled release applications. Recent innovations include DS 700 water-resistant capsules and alginate-based technologies derived from starch. The company also offers thought leadership platforms including POLYOX Academy, Controlled Release resources, and Excipient Insights.

Differentiator

Problem solved

Functional benefit

Brands

• METHONOVA™: Products for biomedical and biological applications
• NovaMatrix®
• NovaMatrix-3D™
• POLYOX™
• METHOCEL™
• Roquette Beauté
• AnswerCenter

Products and services

• Pharmaceutical Excipients Portfolio Sustainable cellulosics, seaweed extracts, ultrapure biopolymers, and specialized synthetic polymers for pharmaceutical manufacturers, supported by polymer expertise across the entire drug development pipeline.
• POLYOX™ Polyethylene Oxide Polymers Polyethylene oxide polymers for pharmaceutical applications, used in controlled release and other drug delivery capabilities, backed by the POLYOX Academy thought leadership platform.
• METHOCEL™ HPMC Hydroxypropyl methylcellulose polymer for controlled release pharmaceutical applications, including a Low Nitrite variant awarded the 2025 NIE New Ingredient Award.
• Dietary Supplement Ingredients Clean-label and great-tasting dietary supplement formats including gummies and plant-based softgels, supported by technical expertise and market understanding throughout nutraceutical formulation and manufacturing.
• METHONOVA™ Biomedical Products Biomedical and biological products portfolio powered by high-quality biopolymers for specialized biotechnology applications.
• NovaMatrix® Biopolymers High-quality biopolymer products for biomedical and life science applications, supported by comprehensive biotechnology solutions and polymer expertise.
• NovaMatrix-3D™ Advanced 3D biomedical and biological applications powered by biopolymer technology.
• DS 700 Water-Resistant Capsule Water-resistant capsule with nearly 100% resistance designed for long-lasting beauty and pharmaceutical applications.
• Alginate-Based Formulations Starch-derived alginate-based formulations offering enhanced rheology and viscosity impacts for cosmetic and pharmaceutical applications.

Quantifiable outcome

• DS 700 water-resistant capsule delivers nearly 100% water resistance for long-lasting applications

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Evonik Industries: Specialty chemicals company with a Healthcare & Life Sciences division producing pharmaceutical excipients, drug delivery polymers (e.g., EUDRAGIT), and APIs. Overlaps directly with the controlled-release and specialty polymer franchise of Roquette Health & Pharma Solutions.
• DuPont Nutrition & Biosciences (now part of IFF, but specialty excipient operations continue under separate entities): DuPont's specialty products business includes cellulosics and pharmaceutical-grade polymers (e.g., ETHOCEL). Competes with IFF/Roquette in pharmaceutical excipients and shares heritage in cellulosic polymer technology.
• BASF SE: Global chemical major with a broad pharmaceutical excipients and active ingredient portfolio (e.g., Kollidon, Kolliphor, PVP-based systems). Competes with Roquette Health & Pharma Solutions across multiple polymer excipient categories and serves the same large pharma customers.
• Merck KGaA Life Science (MilliporeSigma): Life science arm of Merck KGaA supplying pharmaceutical excipients, bioprocessing materials, and lab solutions. Overlaps with Roquette Health & Pharma Solutions on the biomedical/biologics side (METHONOVA, NovaMatrix biopolymers) and broader excipient supply.

Direct peers

• SPI Pharma: Pharmaceutical excipient and drug delivery company specializing in antacid actives, vaccine adjuvants, and patient-friendly dosage formats. Comparable niche-specialty positioning targeting the same pharma manufacturers and formulation challenges.
• Colorcon: Specialty excipient and coating systems company focused on oral solid dose pharmaceutical and nutraceutical applications. Closely competes with METHOCEL HPMC-based coatings, controlled-release platforms, and dietary supplement clean-label formats offered by Roquette Health & Pharma Solutions.
• JRS Pharma (J. Rettenmaier & Söhne): Specialty excipient manufacturer focused on cellulose-based excipients (MCC, microcrystalline cellulose, croscarmellose sodium, HPMC). Direct competitor in the cellulosic excipient franchise that underpins Roquette Health & Pharma Solutions' pharmaceutical business.
• Ashland Global Holdings: Specialty chemical company with a significant pharmaceutical excipients and oral solid dose franchise (e.g., cellulosics, coating systems, controlled-release polymers). Direct competitor to IFF/Roquette's HPMC and POLYOX-based offerings for pharma formulation.

Emerging players

• Tate & Lyle: Specialty food and beverage ingredients company expanding into pharma-grade and clean-label excipients. Adjacent competitor in the dietary supplement and nutraceutical excipient space where Roquette Health & Pharma Solutions operates.
• Ingredion Incorporated: Specialty ingredient company with growing pharma and nutraceutical excipient lines (e.g., starch-based, clean-label ingredients). Increasingly comparable to Roquette Health & Pharma Solutions' dietary supplement and starch-derived alginate platforms.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@RoquetteHealthPharmaSolutions
• LinkedInlinkedin.com/company/about

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharma Solutions at IFF